Raymund A. C. Roos
#136,908
Most Influential Person Now
Raymund A. C. Roos's AcademicInfluence.com Rankings
Raymund A. C. Roosmedical Degrees
Medical
#2390
World Rank
#2812
Historical Rank
Neurology
#225
World Rank
#303
Historical Rank
Raymund A. C. Roosphilosophy Degrees
Philosophy
#6966
World Rank
#10100
Historical Rank
Logic
#4046
World Rank
#5289
Historical Rank
Download Badge
Medical Philosophy
Raymund A. C. Roos's Degrees
- Doctorate Medicine Leiden University
- PhD Neurology Leiden University
Why Is Raymund A. C. Roos Influential?
(Suggest an Edit or Addition)Raymund A. C. Roos's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Huntington's disease: a clinical review (2010) (918)
- Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data (2009) (872)
- Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data (2013) (683)
- Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis (2011) (530)
- Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24 month observational data (2012) (472)
- Amyloid beta protein precursor gene and hereditary cerebral hemorrhage with amyloidosis (Dutch). (1990) (463)
- Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease (2013) (395)
- Orexin loss in Huntington's disease. (2005) (265)
- Influence of dopaminergic medication on automatic postural responses and balance impairment in Parkinson's disease (1996) (234)
- Neurofilament light protein in blood as a potential biomarker of neurodegeneration in Huntington's disease: a retrospective cohort analysis (2017) (224)
- Sleep, excessive daytime sleepiness and fatigue in Parkinson's disease (1993) (213)
- Characterization and localization of the Huntington disease gene product. (1993) (205)
- Prevalence of subjective dysphagia in community residents aged over 87. (1990) (194)
- Observing Huntington’s Disease: the European Huntington’s Disease Network’s REGISTRY (2011) (186)
- Sleep disruption in Parkinson's disease. Assessment by continuous activity monitoring. (1994) (178)
- Pathophysiology of chorea and bradykinesia in Huntington's disease (1999) (175)
- Atrophy of the Hypothalamic Lateral Tuberal Nucleus in Huntington's Disease (1990) (173)
- The Cerebral β‐Amyloid Angiopathies: Hereditary and Sporadic (2006) (164)
- Transient loss of consciousness: The value of the history for distinguishing seizure from syncope (1991) (160)
- The MPTP model: versatile contributions to the treatment of idiopathic Parkinson's disease (1990) (160)
- Dementia in hereditary cerebral hemorrhage with amyloidosis‐Dutch type is associated with cerebral amyloid angiopathy but is independent of plaques and neurofibrillary tangles (2001) (149)
- Efficacy of community-based physiotherapy networks for patients with Parkinson's disease: a cluster-randomised trial (2010) (147)
- Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington's disease. (2010) (141)
- Behavioural problems in Huntington's disease using the Problem Behaviours Assessment. (2008) (137)
- Cholinergic neuronal defect without cell loss in Huntington's disease. (2006) (133)
- Early changes in white matter pathways of the sensorimotor cortex in premanifest Huntington's disease (2012) (131)
- Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease (2012) (129)
- Autonomic nervous system dysfunction in Parkinson's disease: relationships with age, medication, duration, and severity. (1993) (126)
- Increased hypothalamic-pituitary-adrenal axis activity in Huntington's disease. (2009) (126)
- Early atrophy of pallidum and accumbens nucleus in Huntington’s disease (2010) (123)
- Clinical and genetic analysis of a large Dutch family with autosomal dominant vascular retinopathy, migraine and Raynaud's phenomenon. (1998) (122)
- Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program. (1994) (121)
- Hypocretin and Melanin‐Concentrating Hormone in Patients with Huntington Disease (2008) (120)
- Weight loss in neurodegenerative disorders (2008) (119)
- Unified Huntington's disease rating scale: A follow up (1998) (118)
- Adverse effects of predictive testing for Huntington disease underestimated: long-term effects 7-10 years after the test. (2004) (117)
- Hereditary cerebral hemorrhage with amyloidosis-Dutch type (1990) (117)
- Clinimetrics of postural instability in Parkinson’s disease (1998) (116)
- Compensation in Preclinical Huntington's Disease: Evidence From the Track-On HD Study (2015) (116)
- Clozapine versus placebo in Huntington’s disease: a double blind randomised comparative study (1997) (115)
- Mutant huntingtin represses CBP, but not p300, by binding and protein degradation (2005) (112)
- Duration of illness in Huntington's disease is not related to age at onset. (1993) (109)
- Protease nexin-2/amyloid beta protein precursor. A tight-binding inhibitor of coagulation factor IXa. (1993) (108)
- Postural instability in Parkinson’s disease: the adrenergic hypothesis and the locus coeruleus (2009) (107)
- The cerebral beta-amyloid angiopathies: hereditary and sporadic. (2006) (107)
- Hereditary Cerebral Hemorrhage with Amyloidosis‐Dutch Type (HCHWA‐D): I ‐ A Review of Clinical, Radiologic and Genetic Aspects (1996) (106)
- Accumulation of aberrant ubiquitin induces aggregate formation and cell death in polyglutamine diseases. (2004) (104)
- Juvenile Huntington disease (1986) (102)
- Diurnal effects of motor activity and fatigue in Parkinson's disease. (1993) (100)
- On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch program. (1993) (100)
- Living with Huntington's disease: Illness perceptions, coping mechanisms, and patients' well-being. (2002) (100)
- Hereditary Cerebral Hemorrhage with Amyloidosis‐Dutch type (HCHWA‐D): II ‐ A Review of Histopathological Aspects (1996) (98)
- Cross-sectional study on prevalences of psychiatric disorders in mutation carriers of Huntington's disease compared with mutation-negative first-degree relatives. (2008) (94)
- Distribution of inclusions in neuronal nuclei and dystrophic neurites in Huntington disease brain. (1999) (94)
- The benefits of a standardized patient education program for patients with Parkinson's disease and their caregivers. (2010) (92)
- Age at onset in Huntington's disease: effect of line of inheritance and patient's sex. (1991) (92)
- Repetitive behaviors in Tourette's syndrome and OCD with and without tics: what are the differences? (2001) (92)
- DNA-testing for Huntington's disease in The Netherlands: a retrospective study on psychosocial effects. (1992) (92)
- Postural reflexes in Parkinson's disease during ‘resist’ and ‘yield’ tasks (1995) (90)
- Secondary microvascular degeneration in amyloid angiopathy of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type (HCHWA-D) (1998) (89)
- Investigation of Gait in Elderly Subjects Over 88 Years of Age (1992) (89)
- The structural correlates of functional deficits in early huntington's disease (2013) (89)
- CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion (2012) (87)
- Presymptomatic DNA testing for Huntington disease: identifying the need for psychological intervention. (1993) (86)
- Delayed onset of the diurnal melatonin rise in patients with Huntington’s disease (2009) (85)
- Selective vulnerability of Rich Club brain regions is an organizational principle of structural connectivity loss in Huntington’s disease (2015) (83)
- Amyloid β Protein (Aβ) Starts to Deposit As Plasma Membrane‐Bound Form in Diffuse Plaques of Brains from Hereditary Cerebral Hemorrhage with Amyloidosis‐Dutch Type, Alzheimer Disease and Nondemented Aged Subjects (2000) (83)
- A placebo-controlled evaluation of ropinirole, a novel D2 agonist, as sole dopaminergic therapy in Parkinson's disease. (1998) (83)
- Current Pharmacological Approaches to Reduce Chorea in Huntington’s Disease (2016) (83)
- A genetic association study of glutamine-encoding DNA sequence structures, somatic CAG expansion, and DNA repair gene variants, with Huntington disease clinical outcomes (2019) (83)
- A review of cognition in Huntington's disease. (2013) (80)
- Psychological effects of presymptomatic DNA testing for Huntington's disease in the Dutch program. (1994) (79)
- Antipsychotic-induced extrapyramidal syndromes and cytochrome P450 2D6 genotype: a case-control study. (2002) (78)
- Exploratory 7-Tesla magnetic resonance spectroscopy in Huntington’s disease provides in vivo evidence for impaired energy metabolism (2011) (77)
- Ubiquitin-conjugating enzyme E2-25K increases aggregate formation and cell death in polyglutamine diseases (2007) (76)
- Gastrointestinal dysfunction contributes to weight loss in Huntington's disease mice (2011) (75)
- Dementia in hereditary cerebral hemorrhage with amyloidosis-Dutch type. (1990) (75)
- Hereditary cerebral hemorrhage with amyloidosis-Dutch type. Clinical and computed tomographic analysis of 24 cases. (1990) (74)
- Brain Regions Showing White Matter Loss in Huntington’s Disease Are Enriched for Synaptic and Metabolic Genes (2017) (73)
- Illness perceptions and coping explain well-being in patients with Huntington's disease (2006) (73)
- Where to record motor activity: an evaluation of commonly used sites of placement for activity monitors. (1993) (72)
- Psychological studies in Huntington's disease: making up the balance (2001) (72)
- Basal ganglia volume and clinical correlates in ‘preclinical’ Huntington’s disease (2008) (71)
- Association of Vascular Amyloid β and Cells of the Mononuclear Phagocyte System in Hereditary Cerebral Hemorrhage with Amyloidosis (Dutch) and Alzheimer Disease (1997) (70)
- Suprachiasmatic nucleus neuropeptide expression in patients with Huntington's Disease. (2013) (68)
- Suicidal ideation in a European Huntington's disease population. (2013) (68)
- A new approach in the assessment of motor activity in Parkinson's disease. (1991) (67)
- Long latency postural responses are functionally modified by cognitive set. (1991) (67)
- Reliability and factor structure of the Short Problem Behaviors Assessment for Huntington's disease (PBA-s) in the TRACK-HD and REGISTRY studies. (2015) (67)
- A randomized, controlled trial of a multi-modal exercise intervention in Huntington's disease. (2016) (66)
- Huntington's disease biomarker progression profile identified by transcriptome sequencing in peripheral blood (2015) (66)
- Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy — Results from the TRACK-HD study (2011) (66)
- Quality of life in couples living with Huntington’s disease: the role of patients’ and partners’ illness perceptions (2007) (64)
- Caregiver education in Parkinson’s disease: formative evaluation of a standardized program in seven European countries (2009) (64)
- Electrophysiological correlates of postural instability in Parkinson's disease. (1991) (62)
- Cognitive and motor functioning in gene carriers for Huntington's disease: a baseline study. (2003) (60)
- Systemic energy homeostasis in Huntington's disease patients (2010) (60)
- Bone Marrow Stromal Cell-Mediated Tissue Sparing Enhances Functional Repair after Spinal Cord Contusion in Adult Rats (2012) (59)
- Reduced functional brain connectivity prior to and after disease onset in Huntington's disease☆☆☆ (2013) (59)
- Neuronal distribution in the putamen in Huntington's disease. (1985) (59)
- Correlates of apathy in Huntington's disease. (2010) (57)
- Somatic expansion of the (CAG)n repeat in Huntington disease brains (1995) (56)
- Late-onset Huntington disease with intermediate CAG repeats: true or false? (2010) (56)
- Autosomal Dominant Adult Neuronal Ceroid Lipofuscinosis: a Novel Form of NCL with Granular Osmiophilic Deposits without Palmitoyl Protein Thioesterase 1 Deficiency (2003) (55)
- Aspiration pneumonia and death in Huntington’s disease (2012) (55)
- The effect of a polyurethane-based reverse thermal gel on bone marrow stromal cell transplant survival and spinal cord repair. (2014) (55)
- The reliability of commonly used electrophysiology measures (2017) (54)
- Living with huntington’s disease: illness perceptions, coping mechanisms, and spouses’ quality of life (2002) (54)
- A double-blind study of the efficacy of apomorphine and its assessment in ‘off’-periods in Parkinson's disease (1993) (53)
- Hereditary cerebral hemorrhage with amyloidosis — Dutch type: its importance for Alzheimer research (1991) (53)
- Neurofilament light protein in blood predicts regional atrophy in Huntington disease (2018) (53)
- Acute myelopathy caused by fibrocartilaginous emboli (1981) (52)
- Elevated brain iron is independent from atrophy in Huntington's Disease (2012) (52)
- The impact of occipital lobe cortical thickness on cognitive task performance: An investigation in Huntington's Disease (2015) (52)
- Dysphagia in Ambulant Patients with Parkinson's Disease: common, not dangerous (1994) (52)
- Strong aggregation and increased toxicity of polyleucine over polyglutamine stretches in mammalian cells. (2002) (52)
- Amyloid β precursor protein-mRNA is expressed throughout cerebral vessel walls (1999) (52)
- Sydenham's chorea: a practical overview of the current literature. (2010) (51)
- Quantitative assessment of parkinsonian patients by continuous wrist activity monitoring. (1993) (51)
- Hereditary cerebral haemorrhage with amyloidosis--Dutch type. Magnetic resonance imaging findings in 7 cases. (1990) (51)
- Nuclear membrane indentations in Huntington's chorea (1983) (51)
- Longitudinal evaluation of "presymptomatic" carriers of Huntington's disease. (2007) (50)
- The V471A Polymorphism in Autophagy-Related Gene ATG7 Modifies Age at Onset Specifically in Italian Huntington Disease Patients (2013) (50)
- Operationalizing compensation over time in neurodegenerative disease (2017) (49)
- Co‐localization of β/A4 and cystatin C in cortical blood vessels in Dutch, but not in Icelandic hereditary cerebral hemorrhage with amyloidosis (1994) (49)
- The neuroanatomy of subthreshold depressive symptoms in Huntington's disease: a combined diffusion tensor imaging (DTI) and voxel-based morphometry (VBM) study (2013) (48)
- Perception of Emotional Facial Expressions at Different Intensities in Early-Symptomatic Huntington’s Disease (2006) (47)
- Dutch hereditary cerebral amyloid angiopathy: Structural lesions and apolipoprotein E genotype (1997) (46)
- Microvasculopathy is associated with the number of cerebrovascular lesions in hereditary cerebral hemorrhage with amyloidosis, Dutch type. (1998) (45)
- Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa. (2002) (45)
- A review of the assessment of dyskinesias (1999) (45)
- Course of Irritability, Depression and Apathy in Huntington's Disease in Relation to Motor Symptoms during a Two-Year Follow-Up Period (2013) (45)
- Ultrastructural evidence of early non-fibrillar Aβ42 in the capillary basement membrane of patients with hereditary cerebral hemorrhage with amyloidosis, Dutch type (1999) (45)
- Diagnostic genetic testing for Huntington's disease (2014) (44)
- Cognitive decline in Huntington's disease expansion gene carriers (2017) (44)
- Microglia in Diffuse Plaques in Hereditary Cerebral Hemorrhage with Amyloidosis (Dutch). An Immunohistochemical Study (1994) (44)
- Risk of Extrapyramidal Syndromes with Haloperidol, Risperidone, or Olanzapine (2001) (43)
- MRI T2 Hypointensities in basal ganglia of premanifest Huntington's disease (2010) (43)
- Assessment of response fluctuations in Parkinson's disease by ambulatory wrist activity monitoring (1993) (42)
- Progression of motor subtypes in Huntington’s disease: a 6-year follow-up study (2016) (42)
- Cortical tissue of patients with hereditary cerebral hemorrhage with amyloidosis (Dutch) contains various extracellular matrix deposits. (1995) (42)
- Leptin secretion rate increases with higher CAG repeat number in Huntington’s disease patients (2010) (42)
- The contribution of gender differences in motor, behavioral and cognitive features to functional capacity, independence and quality of life in patients with Huntington's disease. (2018) (41)
- Copy-number variation of the neuronal glucose transporter gene SLC2A3 and age of onset in Huntington's disease (2014) (41)
- Evaluation of multi-modal, multi-site neuroimaging measures in Huntington's disease: Baseline results from the PADDINGTON study☆ (2012) (40)
- Quality of life in Huntington's disease: a comparative study investigating the impact for those with pre-manifest and early manifest disease, and their partners. (2013) (40)
- Influence of Bolus Volume on Hyoid Movements in Normal Individuals and Patients with Parkinson's Disease (1994) (40)
- Topological length of white matter connections predicts their rate of atrophy in premanifest Huntington’s disease (2017) (40)
- Syncope or seizure? The diagnostic value of the EEG and hyperventilation test in transient loss of consciousness. (1991) (40)
- 1H magnetic resonance spectroscopy in preclinical Huntington disease (2007) (39)
- The Role of Brain-Derived Neurotrophic Factor in Bone Marrow Stromal Cell-Mediated Spinal Cord Repair (2015) (39)
- Pharmacokinetics, Enantiomer Interconversion, and Metabolism of R‐Apomorphine in Patients with Idiopathic Parkinson's Disease (1998) (38)
- Early grey matter changes in structural covariance networks in Huntington's disease (2016) (37)
- Parent-of-origin differences of mutant HTT CAG repeat instability in Huntington's disease. (2011) (37)
- Grey matter volume loss is associated with specific clinical motor signs in Huntington's disease. (2018) (37)
- Habituation of lower leg stretch responses in Parkinson's disease. (1998) (37)
- Cognitive Function after Spinal or General Anesthesia for Transurethral Prostatectomy in Elderly Men (1991) (36)
- Prevalence of Carriers of Intermediate and Pathological Polyglutamine Disease-Associated Alleles Among Large Population-Based Cohorts. (2019) (36)
- A Computational Cognitive Biomarker for Early-Stage Huntington’s Disease (2016) (36)
- Altered attentional processing of background stimuli in Gilles de la Tourette syndrome: a study in auditory event‐related potentials evoked in an oddball paradigm (1994) (36)
- Normal and mutant HTT interact to affect clinical severity and progression in Huntington disease (2009) (35)
- Stepwise Intravenous Infusion of Apomorphine to Determine the Therapeutic Window in Patients with Parkinson's Disease (1998) (34)
- Longitudinal Diffusion Tensor Imaging Shows Progressive Changes in White Matter in Huntington's Disease. (2015) (34)
- Huntingtin gene repeat size variations affect risk of lifetime depression (2017) (33)
- Neuropsychiatry and White Matter Microstructure in Huntington’s Disease (2015) (33)
- Incidence, course, and predictors of apathy in Huntington's disease: a two-year prospective study. (2011) (32)
- Correction for the influence of background muscle activity on stretch reflex amplitudes (1993) (32)
- Glial reactions and the clearance of amyloid β protein in the brains of patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type (2004) (31)
- Respiration during sleep in Huntington's chorea (1988) (31)
- White matter predicts functional connectivity in premanifest Huntington's disease (2017) (31)
- Subtle involuntary movements are not reliable indicators of incipient Huntington's disease (1998) (31)
- Analysis of the subcellular localization of huntingtin with a set of rabbit polyclonal antibodies in cultured mammalian cells of neuronal origin: comparison with the distribution of huntingtin in Huntington's disease autopsy brain. (1999) (30)
- Fukuyama type congenital muscular dystrophy—Two Dutch siblings— (1984) (30)
- Unified Huntington's disease rating scale for advanced patients: Validation and follow‐up study (2013) (30)
- Weight loss in Huntington's disease. (1992) (30)
- Association of CAG Repeats With Long-term Progression in Huntington Disease. (2019) (30)
- Longitudinal resting state fMRI analysis in healthy controls and premanifest Huntington's disease gene carriers: A three‐year follow‐up study (2015) (29)
- White matter lesions and cognitive deterioration in presymptomatic carriers of the amyloid precursor protein gene codon 693 mutation. (1996) (29)
- Hereditary cerebral hemorrhage with amyloidosis dutch type (AβPP 693): decreased plasma amyloid-β 42 concentration (2003) (29)
- Paroxysmal kinesigenic choreoathetosis as presenting symptom of multiple sclerosis. (1991) (29)
- Corpus callosal atrophy in premanifest and early Huntington's disease. (2013) (29)
- Dose-Dependent Lowering of Mutant Huntingtin Using Antisense Oligonucleotides in Huntington Disease Patients. (2018) (29)
- Recommendations for the Use of Automated Gray Matter Segmentation Tools: Evidence from Huntington’s Disease (2017) (29)
- Thinking about the end of life: a common issue for patients with Huntington’s disease (2014) (28)
- Numerous and widespread α-synuclein-negative Lewy bodies in an asymptomatic patient (1999) (28)
- Memory activation reveals abnormal EEG in preclinical Huntington's disease (2007) (27)
- Behavioural complaints in participants who underwent predictive testing for Huntington’s disease (2002) (27)
- The Patient Education Program for Huntington's Disease (PEP-HD). (2012) (27)
- Driving with a neurodegenerative disorder: an overview of the current literature (2017) (27)
- Acute phase proteins but not activated microglial cells are present in parenchymal β A4 deposits in the brains of patients with hereditary cerebral hemorrhage with amyloidosis-Dutch type (1992) (27)
- Evaluating multicenter DTI data in Huntington's disease on site specific effects: An ex post facto approach☆ (2013) (27)
- Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis–dutch type share a decrease in cerebrospinal fluid levels of amyloid β‐protein precursor (1992) (26)
- Hypothalamic‐Pituitary‐Adrenal Axis Functioning in Huntington's Disease and its Association with Depressive Symptoms and Suicidality (2015) (26)
- Cognitive Performance and Apathy Predict Unemployment in Huntington's Disease Mutation Carriers. (2018) (26)
- Bradykinesia and hypokinesia in Parkinson's disease: what's in a name? (1998) (25)
- Cytochrome P450 and Parkinson's disease Poor parahydroxylation of phenytoin (1990) (25)
- 8OHdG is not a biomarker for Huntington disease state or progression (2013) (25)
- Longitudinal metabolite changes in Huntington's disease during disease onset. (2014) (25)
- Dynamics of the connectome in Huntington's disease: A longitudinal diffusion MRI study (2015) (24)
- Mortality from hereditary cerebral haemorrhage with amyloidosis--Dutch type. The impact of sex, parental transmission and year of birth. (1997) (24)
- Hereditary cerebral hemorrhage with amyloidosis — Dutch type (1989) (24)
- Clinical aspects of cerebral amyloid angiopathy. (1994) (24)
- Neuronal Intranuclear and Neuropil Inclusions for Pathological Assessment of Huntington’s Disease (2007) (24)
- Hereditary cerebral hemorrhage with amyloidosis--Dutch type (HCHWA-D): a review of the variety in phenotypic expression. (1999) (24)
- NMDA receptor gene variations as modifiers in Huntington disease: a replication study (2011) (24)
- Congenital microcephaly, infantile spasms, psychomotor retardation, and nephrotic syndrome in two sibs (1987) (23)
- A disease-specific psychosocial questionnaire for Parkinson’s disease caregivers (2003) (23)
- Hereditary cerebral hemorrhage with amyloidosis Dutch type (AbetaPP 693): decreased plasma amyloid-beta 42 concentration. (2003) (23)
- Therapeutic strategies for circadian rhythm and sleep disturbances in Huntington disease. (2015) (22)
- Islet β-cell area and hormone expression are unaltered in Huntington’s disease (2008) (22)
- MRI biomarkers in Huntington's disease. (2012) (22)
- Altered postural reflexes in Parkinson's disease: a reverse hypothesis. (1992) (22)
- Deficient sustained attention to response task and P300 characteristics in early Huntington’s disease (2011) (21)
- Short-interval observational data to inform clinical trial design in Huntington's disease (2015) (21)
- Euthanasia and advance directives in Huntington's disease: qualitative analysis of interviews with patients. (2013) (21)
- Striatal metabolism and psychomotor speed as predictors of motor onset in Huntington’s disease (2014) (21)
- Cross-sectional and longitudinal voxel-based grey matter asymmetries in Huntington's disease (2017) (21)
- Seven-year clinical follow-up of premanifest carriers of Huntington's disease (2011) (21)
- Making (anti-) sense out of huntingtin levels in Huntington disease (2015) (20)
- Irritability in a Prospective Cohort of Huntington's Disease Mutation Carriers. (2015) (20)
- Antipsychotics and Parkinson's disease: association with disease and drug choice during the first 5 years of antiparkinsonian drug treatment (2002) (20)
- Mutant huntingtin represses CBP, but not p300, by binding and protein degradation. (2005) (20)
- Epitope mapping of monoclonal antibody 4C8 recognizing the protein huntingtin. (2005) (19)
- Acute myelopathy caused by fibrocartilaginous emboli (1981) (19)
- Aspiration pneumonia and death in Huntington's disease. (2012) (18)
- Modest proteasomal inhibition by aberrant ubiquitin exacerbates aggregate formation in a Huntington disease mouse model (2010) (18)
- Antiparkinsonian drugs causing inappropriate antidiuretic hormone secretion (1998) (18)
- Reducing macrophages to improve bone marrow stromal cell survival in the contused spinal cord (2010) (18)
- Structural and functional changes of the visual cortex in early Huntington's disease (2018) (17)
- A plea for end-of-life discussions with patients suffering from Huntington's disease: the role of the physician (2012) (17)
- Eye-of-the-tiger-sign in a 48year healthy adult (2014) (17)
- Apathy predicts rate of cognitive decline over 24 months in premanifest Huntington's disease (2020) (17)
- Medium latency stretch reflexes in young-onset Parkinson's disease and MPTP-induced parkinsonism (1994) (17)
- Numerous and widespread alpha-synuclein-negative Lewy bodies in an asymptomatic patient. (1999) (17)
- The clinimetrics of hypokinesia in Parkinson's disease: Subjective versus objective assessment (1994) (17)
- Hereditary cerebral hemorrhage with amyloidosis (Dutch): a model for congophilic plaque formation without neurofibrillary pathology (2004) (16)
- International (NL-UK) double-blind study of Sinemet CR and standard Sinemet (25/100) in 170 patients with fluctuating Parkinson's disease (1996) (16)
- Natural variation in sensory‐motor white matter organization influences manifestations of Huntington's disease (2016) (16)
- EEG may serve as a biomarker in Huntington’s disease using machine learning automatic classification (2018) (16)
- Hypocretin-1 and secondary signs in Huntington's disease. (2007) (16)
- Natural biological variation of white matter microstructure is accentuated in Huntington's disease (2018) (15)
- Visual Working Memory Impairment in Premanifest Gene-Carriers and Early Huntington's Disease. (2012) (15)
- Potential for imaging cerebral amyloid deposits using 123I-labelled serum amyloid P component and SPET. (1996) (15)
- Fatigue in Parkinson's disease is not associated with reduced physical activity. (1997) (15)
- Longitudinal pilot-study of Sustained Attention to Response Task and P300 in manifest and pre-manifest Huntington's disease. (2015) (15)
- [Drug therapy in Parkinson's disease]. (1999) (15)
- Cerebral vascular accumulation of Dutch‐type Aβ42, but not wild‐type Aβ42, in hereditary cerebral hemorrhage with amyloidosis, Dutch type (2007) (15)
- Disease Onset in Huntington's Disease: When Is the Conversion? (2021) (14)
- Nature and Development of Huntington Disease in a Nursing Home Population: The Behavior Observation Scale Huntington (BOSH) (2005) (14)
- Trigeminal Neuralgia‐Like Pain in an Aged Woman with Fibrous Dysplasia of the Skull Base (1990) (14)
- Executive Impairment Is Associated with Unawareness of Neuropsychiatric Symptoms in Premanifest and Early Huntington’s Disease (2018) (14)
- The visual cortex and visual cognition in Huntington’s disease: An overview of current literature (2018) (14)
- Plasma Cytokine Levels in Relation to Neuropsychiatric Symptoms and Cognitive Dysfunction in Huntington's disease. (2016) (14)
- Bioenergetics in fibroblasts of patients with Huntington disease are associated with age at onset (2018) (14)
- The Effect of Music Therapy in Patients with Huntington's Disease: A Randomized Controlled Trial. (2017) (14)
- Magnetization transfer imaging in ‘premanifest’ Huntington’s disease (2009) (14)
- Neuronal nuclear membrane indentation and astrocyte/neuron ratio in Huntington's disease. A quantitative electron microscopic study. (1985) (14)
- The role of iron imaging in Huntington's disease. (2013) (14)
- Pseudotumor Cerebri associated with Hypovitaminos is A and Hyperthyroidism (1985) (14)
- Large‐scale brain network abnormalities in Huntington's disease revealed by structural covariance (2016) (14)
- Stem Cells for Central Nervous System Repair and Rehabilitation (2011) (13)
- Falling spells in normal pressure hydrocephalus: a favourable prognostic sign? (1987) (13)
- Texture analysis of ultrahigh field T2*‐weighted MR images of the brain: Application to Huntington's disease (2014) (12)
- Defining pediatric huntington disease: Time to abandon the term Juvenile Huntington Disease? (2019) (12)
- Morphology of cerebral plaque-like lesions in hereditary cerebral hemorrhage with amyloidosis (Dutch) (2004) (12)
- High prevalence of vitamin D deficiency and insufficiency in patients with manifest Huntington disease (2013) (12)
- Cognition in Huntington's disease in manifest, premanifest and converting gene carriers over ten years. (2013) (12)
- Therapeutic options for Huntington's disease. (2003) (12)
- Antidopaminergic Medication is Associated with More Rapidly Progressive Huntington's Disease. (2015) (12)
- Survival End Points for Huntington Disease Trials Prior to a Motor Diagnosis (2017) (12)
- Comparison between the Icelandic and Dutch forms of hereditary cerebral amyloid angiopathy (1992) (11)
- Exploring Genetic Factors Involved in Huntington Disease Age of Onset: E2F2 as a New Potential Modifier Gene (2015) (11)
- Combined cerebral atrophy score in Huntington's disease based on atlas-based MRI volumetry: Sample size calculations for clinical trials. (2019) (11)
- Apathy and atrophy of subcortical brain structures in Huntington's disease: A two-year follow-up study (2018) (11)
- Electroencephalography in autosomal dominant adult neuronal ceroid lipofuscinosis (2009) (11)
- Altered Intracortical T1-Weighted/T2-Weighted Ratio Signal in Huntington’s Disease (2018) (11)
- Repeat length variations in polyglutamine disease-associated genes affect body mass index (2018) (11)
- The prevalence and the burden of pain in patients with Huntington disease: a systematic review and meta-analysis (2019) (11)
- Is There Convincing Evidence that Intermediate Repeats in the HTT Gene Cause Huntington's Disease? (2015) (11)
- Enhanced Aβ40 Deposition Was Associated with Increased Aβ42/43 in Cerebral Vasculature with Dutch‐Type Hereditary Cerebral Hemorrhage with Amyloidosis (HCHWA‐D) (2002) (11)
- The unified huntington's disease rating scale for advanced patients: Validation and follow‐up study (2013) (11)
- Copy-number variation of the neuronal glucose transporter gene SLC 2 A 3 and age of onset in Huntington ’ s disease (2014) (10)
- Hereditary Cerebral Hemorrhage with Amyloidosis—Dutch Type: A Congophilic Angiopathy (1991) (10)
- Age of onset in Huntington's disease is influenced by CAG repeat variations in other polyglutamine disease-associated genes. (2017) (10)
- Impact of the control for corrupted diffusion tensor imaging data in comparisons at the group level: an application in Huntington disease (2014) (10)
- Phenytoin parahydroxylation is not impaired in patients with young-onset Parkinson's disease (1994) (10)
- Antipsychotic-induced extrapyramidal syndromes. Risperidone compared with low- and high-potency conventional antipsychotic drugs. (2001) (10)
- Interrater Reliability of the Unified Huntington's Disease Rating Scale‐Total Motor Score Certification (2018) (10)
- [Driving with Alzheimer's disease]. (2017) (10)
- No protective effect of apolipoprotein e ε2 allele in dutch hereditary cerebral amyloid angiopathy (1995) (10)
- Decreased hypothalamic prohormone convertase expression in huntington disease patients. (2013) (9)
- Characteristics, pathophysiology and clinical management of weight loss in Huntington’s disease (2013) (9)
- Periodic fever: an unusual manifestation of a recurrent Rathke's cleft. (1990) (9)
- Influence of benzodiazepines on antiparkinsonian drug treatment in levodopa users (2002) (9)
- [Presymptomatic DNA diagnosis in Huntington's chorea: reactions to the certainty of not being a genetic carrier]. (1990) (9)
- Reply: Late onset Huntington's disease with 29 CAG repeat expansion (2016) (8)
- Gel Isoelectric Focusing and IgG Index for Demonstration of Intrathecal IgG Synthesis in Neurological Disorders (1981) (8)
- Measurement of Psychopathology in Huntington's Disease: The Critical Role of Caregivers (2010) (8)
- Longitudinal assessment of the Unified Huntington's Disease Rating Scale (UHDRS) and UHDRS–For Advanced Patients (UHDRS‐FAP) in patients with late stage Huntington's disease (2019) (8)
- Improving quality of life in patients with Huntington’s disease through music therapy: A qualitative explorative study using focus group discussions (2018) (8)
- Quantification of choreatic movements by Doppler radar (1982) (8)
- The potential of composite cognitive scores for tracking progression in Huntington's disease. (2012) (8)
- Music therapy in Huntington’s disease: a protocol for a multi-center randomized controlled trial (2016) (8)
- Detection of Motor Changes in Huntington's Disease Using Dynamic Causal Modeling (2015) (8)
- Design optimization for clinical trials in early‐stage manifest Huntington's disease (2017) (8)
- Motor dysfunction influence on executive functioning in manifest and premanifest Huntington's disease (2014) (8)
- Progressive microstructural changes of the occipital cortex in Huntington’s disease (2018) (7)
- Presenilin‐I polymorphism and hereditary cerebral hemorrhage with amyloidosis, Dutch type (1997) (7)
- Perhaps the subject of the questionnaire was too sensitive: Do we expect too much too soon? Wishes for the end of life in Huntington's Disease - the perspective of European physicians. (2014) (7)
- Antipsychotic-induced Extrapyramidal Syndromes in Psychiatric Practice: A Case-control Study (2005) (7)
- Disulfiram polyneuropathy (1984) (7)
- Huntington's Disease Gene Expansion Carriers Are Aware of Their Degree of Apathy. (2018) (7)
- Diagnosing Juvenile Huntington’s Disease: An Explorative Study among Caregivers of Affected Children (2020) (7)
- Small N-terminal mutant huntingtin fragments, but not wild type, are mainly present in monomeric form: Implications for pathogenesis (2006) (7)
- Predictors of simulated driving performance in Huntington's disease. (2019) (7)
- Atrophy of the putamen at time of clinical motor onset in Huntington’s disease: a 6-year follow-up study (2018) (7)
- Prolonged duration of standing up is an early dopa-sensitive abnormality in Parkinson's disease (1997) (7)
- Premanifest Huntington’s disease: Examination of oculomotor abnormalities in clinical practice (2018) (6)
- Visual Object Perception in Premanifest and Early Manifest Huntington’s Disease (2019) (6)
- Assessment Scales for Patients with Advanced Huntington's Disease: Comparison of the UHDRS and UHDRS‐FAP (2018) (6)
- Composite UHDRS Correlates With Progression of Imaging Biomarkers in Huntington's Disease (2021) (6)
- Medication Use in Early-HD Participants in Track-HD: an Investigation of its Effects on Clinical Performance (2016) (6)
- Cystathionine Levels in Patients With Huntington Disease (2015) (6)
- Familial amyloidotic polyneuropathy (1989) (6)
- Does arterial hypertension influence the onset of Huntington's disease? (2018) (6)
- Stability and sensitivity of structural connectomes: effect of thresholding and filtering and demonstration in neurodegeneration (2018) (6)
- Postural reflexes in patients on long-term neuroleptic medication (1991) (6)
- Lumbar disk degeneration in spinal dysraphism. (1990) (6)
- Suicidality in Huntington's Disease: A Qualitative Study on Coping Styles and Support Strategies. (2016) (6)
- Presymptomatic DNA-testing for Huntington disease in The Netherlands. (1992) (6)
- Disease stage and plasma levels of cytokines in Huntington's disease: A 2‐year follow‐up study (2017) (6)
- Lack of GTP-insensitive D2 dopamine receptors in Huntington's disease (1989) (5)
- Comparable rates of simulator sickness in Huntington’s disease and healthy individuals (2019) (5)
- D22 Compensation in preclinical huntington’s disease: evidence from the track-on HD study (2016) (5)
- Euthanasia and physician-assisted suicide in Huntington's disease in The Netherlands (2012) (5)
- No protective effect of apolipoprotein E epsilon 2 allele in Dutch hereditary cerebral amyloid angiopathy. (1995) (5)
- Hereditary Cerebral Hemorrhage with Amyloidosis -Dutch Type: A Study of Fibrinolysis (1992) (5)
- Huntingtin with an expanded polyglutamine repeat affects the Jab1-p27(Kip1) pathway (2012) (5)
- Huntington's disease in Saudi Arabia. (1995) (5)
- Predictors of Working Capacity Changes Related to Huntington's Disease: A Longitudinal Study. (2021) (4)
- Predictive genetic testing in Huntington’s disease: should a neurologist be involved? (2020) (4)
- Use of antipsychotics in Parkinson's disease in daily practice (2002) (4)
- Assessing genetic effects in survival data by correlating martingale residuals with an application to age at onset of Huntington disease (2006) (4)
- [From gene to disease; amyloid-beta precursor protein gene instrumental in hereditary cerebral amyloid angiopathies]. (2001) (4)
- FALLS AND FEAR OF FALLING IN NURSING HOME RESIDENTS WITH HUNTINGTON’S DISEASE (2016) (4)
- P2.082 ParkNet: a multifaceted strategy to implement practice guidelines for physiotherapy in Parkinson's disease (2007) (4)
- Altered driving performance of symptomatic Huntington’s disease gene carriers in simulated road conditions (2018) (4)
- Coexistence of cystatin C and beta protein immunoreactivity. (1990) (4)
- Long-term ambulatory monitoring of urine leakage in the elderly: an evaluation of the validity and clinical applicability of thermistor signalling. (1998) (4)
- Marriage as Protector for Nursing Home Admission in Huntington's Disease. (2018) (4)
- Magnetic resonance imaging in occult spinal dysraphism (2006) (4)
- Effect of disease and drug treatment on blood serotonin and monoamine oxidase B activity in Parkinson's disease (1995) (4)
- Alzheimer A4 peptide, gamma‐trace, leukoencephalopathy, and hereditary cerebral hemorrhage with amyloidosis–dutch type (1991) (3)
- Introduction to the Amyloid Symposium (1996) (3)
- The continuum of hyperthermic syndromes with impaired dopaminergic activity. (1992) (3)
- Function of amyloid and amyloid protein precursor (1992) (3)
- Insulin Sensitivity in De Novo Parkinson's Disease: A Hyperinsulinemic‐Euglycemic Clamp Study (2020) (3)
- Longitudinal Structural MRI in Neurologically Healthy Adults (2020) (3)
- Does midlife obesity really lower dementia risk? (2015) (3)
- Superior clinical efficacy of Sinement CR 50/200 versus Sinemet 25/100 in patients with fluctuating Parkinson's disease. An open and a double-blind, double-dummy, multicenter treatment evaluation. Dutch Sinement CR Study Group. (1993) (3)
- Neuropathology of Hereditary Cerebral Hemorrhage with Amyloidosis-Dutch Type (2000) (3)
- Abstracts of papers (2005) (3)
- Hereditary cerebral hemorrhage with amyloidosis--Dutch type. Research-Group Hereditary Cerebral Amyloid-Angiopathy. (1989) (3)
- Alzheimer's disease and hereditary cerebral hemorrhage with amyloidosis-Dutch type share a decrease in cerebrospinal fluid levels of amyloid beta-protein precursor. (1992) (3)
- Posttraumatic hyperthermia: A possible result of fronto-diencephalic dysfunction (1991) (3)
- Safety, pharmacokinetics and pharmacodynamics of SBT‐020 in patients with early stage Huntington's disease, a 2‐part study (2020) (3)
- Nonlinear effects in behavioral changes in Huntington disease. (2003) (3)
- Unusual metastatic pattern in testicular malignant teratoma. (1983) (3)
- Binding of amyloid β precursor protein to coagulation factor XIa in vivo may favour haemorrhagic stroke (1998) (3)
- [Gait impairment in the oldest old]. (1997) (2)
- Huntington's disease: report of four Saudi families (1996) (2)
- Decrease of antiparkinsonian drugs before start of an antipsychotic in patients on levodopa treatment? (2004) (2)
- High insulinlike growth factor I is associated with cognitive decline in Huntington disease (2011) (2)
- F41 Huntington’s disease gene expansion carriers are aware of their degree of apathy (2018) (2)
- Diagnosis of 1st seizure (1989) (2)
- Quantification of random body movements by a Doppler radar device (1982) (2)
- CAG repeat size in the normal HTT allele and age of onset in Huntington's disease (2011) (2)
- Improving the efficiency of physiotherapeutic care in Parkinson's disease: ParkNet trial. (2005) (2)
- β-Defensin genomic copy number does not influence the age of onset in Huntington's Disease. (2013) (2)
- Functional hypothalamic derangement in a case of Wernicke's encephalopathy. (1990) (2)
- FEAR OF CHOKING AND FEAR OF FALLING IN HUNTINGTON’S DISEASE: STUDY PROTOCOL FOR A MULTI-CENTER OBSERVATIONAL CROSS-SECTIONAL STUDY (2019) (2)
- Sinister Tingling in the Axilla (1991) (2)
- [Procedure and initial results of presymptomatic DNA studies in Huntington's chorea]. (1990) (2)
- PL6.4 Selected oral abstract: ParkNet implementation: evaluation of health bene.ts (2008) (2)
- Measuring the quality of care in nursing home residents with early-onset neurodegenerative diseases: a scoping review (2019) (2)
- Coexistence of Cystatin C and p Protein Immunoreactivity (2005) (1)
- POMD07 Quantitative assessment of biological and clinical manifestations of Huntington's disease before and after diagnosis—the TRACK-HD study (2010) (1)
- HEREDITARY CEREBRAL HEMORRHAGE WITH AMYLOIDOSIS-DUTCH TYPE. REPLY (1993) (1)
- 8. The hypothalamic nucleus tuberis lateralis: a model for neuronal loss in Huntington's disease (1992) (1)
- Impact of the control for corrupted diffusion tensor imaging data in comparisons at the group level: an application in Huntington disease (2014) (1)
- Chapter 4 Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington ’ s disease (2010) (1)
- Stretch reflexes in Parkinson's disease. (1995) (1)
- F04 Quality of life in Huntington's disease: a comparative study investigating the impact on spouses of those with premanifest and early disease (2010) (1)
- β-Defensin Genomic Copy Number Does Not Influence the Age of Onset in Huntington's Disease. (2013) (1)
- Fine distribution of gamma-aminobutyric acid, aspartate and glutamate in human dentate nucleus (1990) (1)
- Autonomic Symptoms in Huntington’s Disease - Current Understanding and Perspectives for the Future (2010) (1)
- Hereditary cerebral hemorrhage with amyloidosis--Dutch type. Tc-99m HM-PAO single photon emission computed tomography. (1990) (1)
- Tardive dyskinesia, WHO expert series on biological psychiatry, vol. 2 H. Haag, E. Ruther and H. Hippius (Ed.), 1992, Hogrefe & Huber Publishers, Kirkland, WA, 124 pages, US$29.00, ISBN 0-88937-086-9 and 3-456-82115-8 (1993) (1)
- Age at onset in Huntington's disease in the Netherlands (1990) (1)
- Clinical and Genetic Aspects of Hereditary Cerebral Hemorrhage with Amyloidosis Dutch Type (HCHW A-D) (2000) (1)
- Validating Automated Segmentation Tools in the Assessment of Caudate Atrophy in Huntington’s Disease (2021) (1)
- 3.405 ParkNet implementation: Evaluation of health benefits (2007) (1)
- F24 Differences in companion and subject ratings of subjects' behaviour using the frontal systems behaviour scale (FrSBe)- findings from the track-hd study (2010) (1)
- P408 Does dystonic EMG-pattern influence the efficacy of botulinum toxin (BTX) in cervical dystonia (CD)? (1996) (0)
- A33 Differences in bioenergetic status in patient-derived fibroblast cells are associated with age of onset in huntington disease (2018) (0)
- D9 An evaluation of methods for the volumetric measurement of grey matter in huntington’s disease (2016) (0)
- E14 Neuroimaging biomarkers in Huntington’s disease (2022) (0)
- Clinical diagnosis and management of Alzheimer's disease by Serge Gauthier (editor), Martin Dunitz Publ., London, 1996, 384 pages, £69.95, ISBN 1-85317-308-8 (1996) (0)
- MATTERS ARISING (1992) (0)
- Weight loss and exercise in obese older adults. (2011) (0)
- Finding the way in the chorea labyrinth Ruth H Walker The Differential (2011) (0)
- Amyotrophic lateral sclerosis: A comprehensive guide to management By Mitsumoto H. and F.H. Norris (editors), 1994, Demos Publ., New York, NY, US $39.95, ISBN 0-939957-58-2 (1995) (0)
- Progressive microstructural abnormalities of the occipital cortex in Huntington's disease (2017) (0)
- Chapter 7 Elevated brain iron is independent from atrophy in Huntington’s Disease (2012) (0)
- Music Therapy in Patients with Huntington’s Disease: A Case Report (2017) (0)
- G02 Attention and inhibition in Huntington's disease (2010) (0)
- A strategy for finding the optimal deconvolution estimates for hormone secretory kinetics using AutoDecon. (2009) (0)
- D21 Longitudinal compensation in the cognitive network in huntington’s disease (2016) (0)
- A22 Hypothalamic changes in Huntington's disease (2010) (0)
- C01 Glutamine codon usage and somatic mosaicism of the HTT cag repeat are modifiers of huntington disease severity (2018) (0)
- Points: Acute central cervical cord injury due to disco dancing (1984) (0)
- Misconceptions and inappropriate use of terms in hyperthermic syndromes. (1991) (0)
- H37 Fear of choking and fear of falling in huntington’s disease (2018) (0)
- Brain Bio-Energetic State Does Not Correlate to Muscle Mitochondrial Function in Huntington's Disease. (2020) (0)
- Subject Index Vol. 27, 1987 (1987) (0)
- Useful questions to separate an epileptic seizure from other causes of transient loss of consciousness (1990) (0)
- Syncope orseizure? Thediagnostic value ofthe EEGandhyperventilation test intransient loss of consciousness (1991) (0)
- The hypothalamic lateral tuberal nucleus in Huntington's disease and Alzheimer's disease (1990) (0)
- E02 Standardising and observing atrophy and cognitive patterns across the lifetime of Huntington’s disease using data from the HD-YAS and TRACK-HD and TrackOn-HD studies (2022) (0)
- The history of juvenile Huntington’s disease (2009) (0)
- H01 Significant biological and clinical change detected over 1 year in premanifest and early stage Huntington's disease in the TRACK-HD study (2010) (0)
- J04 Efficacy and safety of tiapride for chorea treatment in huntington’s disease: a systematic review (2021) (0)
- [Hereditary cerebral amyloid angiopathy and Alzheimer's disease]. (1991) (0)
- FV 21 Heading for imaging read-outs in Huntington’s disease: Sample size calculations for longitudinal automatic MRI volumetry (2019) (0)
- E04 Structure and function of the posterior cerebral cortex in huntington’s disease (2018) (0)
- [Unconsciousness: seizure or not? The importance of the anamnesis in the differential diagnosis of a temporary loss of consciousness]. (1988) (0)
- 18. Autonomic nervous system dysfunction in Parkinson's disease in relation to age, medication, duration and severity (1992) (0)
- [Spina bifida occulta: a minor cosmetic defect?]. (1987) (0)
- Chapter Falls and gait disturbances in Huntington’s disease (2012) (0)
- Clinical disorders of balance, posture and gait edited by A.M. Bronstein, Th. Brandt and M. Woollacott, Arnold Publ., London, 1996, £85.00, ISBN 0-340-601450 (hardbound) (1996) (0)
- D10 Neurofilament light protein in blood predicts regional atrophy in huntington’s disease (2018) (0)
- I27 Participants at the leiden site of the registry study: a demographic approach (2016) (0)
- Abstracts of papers and posters Pharmacological Meeting (1994) (0)
- 7 Improvement scoring of the Rey Auditory Verbal Learning Test (2009) (0)
- [Pain in muscles and joints as the initial symptom of Parkinson disease]. (1989) (0)
- Haemorrhagic necrosis of the grey matter of the spinal cord due to accidental injection of iopamidol in a patient with multiple neurofibromas; a clinico-pathological study (2004) (0)
- Unusual Metastatic Pattern in Testicular Malignant Teratoma (1983) (0)
- Author’s response to reviews Title: Measuring the Quality of Care in Nursing Home Residents with Early-onset Neurodegenerative Diseases: A scoping review Authors: Joyce Heffels (jcf.heffels@landvanhorne.nl) (2020) (0)
- Genetic diagnosis of hyperkinetic movement disorders. (2012) (0)
- Hypointensities in basal ganglia of premanifest Huntington ’ s disease (2017) (0)
- I05 Changes in iron concentrations in Huntington's disease (2010) (0)
- Growth hormone and ghrelin secretion in Huntington’s disease (2010) (0)
- D08 Neurofilament light protein in blood as a potential biomarker of neurodegeneration in hungtington’s disease: a retrospective cohort analysis (2018) (0)
- Alzheimer's disease: towards an understanding of the aetiology and pathogenesis Current problems in Neurology: 11 ed. by D.C. Davies. John Libbey, London, Paris, 1989. ISBN 0 86196 166 8 (1990) (0)
- M12 A randomised, controlled trial of a 12 week multi-modal exercise intervention in huntington’s disease (2016) (0)
- Aβ starts to deposit on cell surface plasma membrane in diffuse plaques (2000) (0)
- In Memoriam (2002) (0)
- J01 Triheptanoin is associated with clinical stability and decreased caudate atrophy in huntington disease (2021) (0)
- I04 Magnetic transfer imaging in premanifest and manifest Huntington's disease: results from the TRACK-HD study (2010) (0)
- H56 Driving performance of huntington’s disease gene carriers (2018) (0)
- Neural Transplantation Methods. Neuromethods, 36, Edited by S.B. Dunnett, A.A. Boulton and G.B. Baker, Humana Press Inc., New Jersey, USA, 2000. ISBN 0-89603-793-2; Hardcover: $125.00 (2000) (0)
- Making (anti-) sense out of huntingtin levels in Huntington disease (2014) (0)
- Short-interval observational data to inform clinical trial design in early Huntington ’ s Disease (2015) (0)
- Chapter 8 Reduced functional brain connectivity prior to disease onset in Huntington’s Disease (2012) (0)
- I46 Polypharmacy in patients with advanced huntington’s disease residing in a nursing home (2016) (0)
- Imaging in Huntington’s disease (2015) (0)
- E2 Progression of motor subtypes in huntington’s disease: a six-year follow-up study (2016) (0)
- An objective method in the assessment of motor activity in Parkinson's disease (1991) (0)
- F14 Speeded tapping assesses progression of huntington's disease within one year—results from the track-HD study (2010) (0)
- M R I in occult spinal dysraphism (1988) (0)
- Lymphocyte concanavalin A capping in hereditary cerebral haemorrhage with amyloidosis — Dutch type (1990) (0)
- I02 Automated longitudinal measures of global and regional brain volume change in premanifest and early Huntington's disease (2010) (0)
- MRI Tz Hypointensities in basal ganglia of premanifest Huntingtons disease (2011) (0)
- 15.18 Improving the efficiency of physiotherapeutic care in Parkinson's disease: the PARKNET trial (2005) (0)
- Neuroendocrine and metabolic abnormalities in Parkinson's and Huntington's disease in relation to the clinical presentation (2009) (0)
- recurrent Rathke ' s cleft . Periodic fever : an unusual manifestation of a (0)
- The Relationship Between Fear of Falling, respectively, Fear of Choking and Emotional and Cognitive Functioning in Huntington’s Disease, Parkinson’s Disease and Dementia: a Review (2017) (0)
- Authors' Reply (2002) (0)
- Participants at the Leiden Site of the REGISTRY Study: A Demographic Approach. (2016) (0)
- F51 Level of dispositional optimism is related to depression and huntington’s disease stage (2018) (0)
- 3.425 Efficacy of the Patient Education Program Parkinson (PEPP) (2007) (0)
- F58 Assessment scales for patients with advanced huntington’s disease: comparison of the UHDRS and UHDRS-FAP (2018) (0)
- F20 Is burnout an early sign of huntington’s disease and more prevalent than in the general population? (2021) (0)
- Lower brain stem dysfunction in huntington's disease (1987) (0)
- Contents, Vol. 27, 1987 (1987) (0)
- D10 Early changes in structural covariance networks in huntington’s disease (2016) (0)
- F21 Cag-dependent huntington’s disease patterns over decades: the track-hd and track-on studies (2018) (0)
- P2.086 A process evaluation of ParkNet implementation (2007) (0)
- Awareness in Huntington’s Disease Manuscript 1 Executive impairment is associated with unawareness of neuropsychiatric symptoms in premanifest and early Huntington’s disease (2018) (0)
- D18 Brain network breakdown and pathophysiological correlates in huntington’s disease (2016) (0)
- E11 Compensation in huntington’s disease (2018) (0)
- Editorial (1992) (0)
- O2-06-02 Accumulation of mutant ubiquitin induces aggregate formation and cell death in polyglutamine diseases (2004) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Raymund A. C. Roos?
Raymund A. C. Roos is affiliated with the following schools:
